Cas:58692-70-9 methyl (3R)-3-hydroxy-3-phenylpropanoate manufacturer & supplier

We serve Chemical Name:methyl (3R)-3-hydroxy-3-phenylpropanoate CAS:58692-70-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl (3R)-3-hydroxy-3-phenylpropanoate

Chemical Name:methyl (3R)-3-hydroxy-3-phenylpropanoate
CAS.NO:58692-70-9
Synonyms:3-hydroxy-3-phenyl-propionic acid methyl ester
Molecular Formula:C10H12O3
Molecular Weight:180.20000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:300.9ºC at 760 mmHg
Density:1.147g/cm3
Index of Refraction:1.528
PSA:46.53000
Exact Mass:180.07900
LogP:1.28310

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-hydroxy-3-phenyl-propionic acid methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-hydroxy-3-phenyl-propionic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-hydroxy-3-phenyl-propionic acid methyl ester Use and application,3-hydroxy-3-phenyl-propionic acid methyl ester technical grade,usp/ep/jp grade.


Related News: Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. methyl (3R)-3-hydroxy-3-phenylpropanoate manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry. methyl (3R)-3-hydroxy-3-phenylpropanoate supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry. methyl (3R)-3-hydroxy-3-phenylpropanoate vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. methyl (3R)-3-hydroxy-3-phenylpropanoate factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.